Social cost of twin births

Insights

Twin pregnancies incur significantly higher neonatal and handicapped care costs, potentially 10 times that of single pregnancies. This economic analysis supports preventive policies aimed at improving twin birthweights to reduce healthcare expenses.

Area of Science:

  • Neonatal care
  • Public health economics
  • Maternal-fetal medicine

Background:

  • Twin pregnancies are associated with adverse birthweight distributions.
  • These distributions lead to increased costs for neonatal intensive care and long-term care for handicapped children.
  • Current healthcare economics do not fully account for the amplified costs of twin births.

Purpose of the Study:

  • To analyze the economic burden of neonatal and handicapped care associated with twin pregnancies.
  • To quantify the cost differences between twin and singleton pregnancies.
  • To advocate for and provide a framework for evaluating preventive strategies targeting twin birthweight.

Main Methods:

  • Economic analysis of healthcare costs.
  • Comparative cost assessment of twin versus singleton pregnancies.
  • Development of a cost-impact model for birthweight interventions.

Main Results:

  • Costs for twin pregnancies can be up to 10 times higher than for singleton pregnancies.
  • The primary driver of increased costs is the unfavorable birthweight distribution in twins.
  • A significant reduction in healthcare expenditure is achievable through policies improving twin birthweights.

Conclusions:

  • Investing in preventive policies for twin pregnancies is economically justified.
  • Reducing the proportion of very low and low birthweight infants in twin births can lead to substantial cost savings.
  • Further research into targeted interventions for twin pregnancies is warranted to optimize birth outcomes and reduce healthcare burdens.

Related Concept Videos

Probability Laws01:49

Probability Laws

Overview
Nondisjunction02:14

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.When...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Nondisjunction02:14

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.When...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...